secondary l-carnitine deficiency Role of carnitine in disease Carnitine Deficiency in Chronic Kidney
Description
International journal of women's health
Address correspondence to: Maureen R
2.1 Hypertension Systemic hypertension is one of the most significant comorbidities in HFpEF patients (Heidenreich et al., 2022)
Tirzepatide is not recommended for individuals with medullary thyroid carcinoma, MEN2, and certain health conditions such as pancreatitis and gallstones
doi: 10.1123/ijsn.7.1.1
18819-8/asset/9f7346ac-840e-419f-83cb-12daeeef65f1/main.assets/gr1_lrg.jpg)
